Search inside SEC filings
Every 10-K, 10-Q, 8-K, proxy and registration statement filed since 2001, searched by what the text actually says. Free, no account, straight through to the document.
At least 10,000 filings contain "Translational"
showing the first 40- Translational Development Acquisition Corp.PRE 14A · 2026-05-01Read the filing on SEC.gov →
- Translational Development Acquisition Corp.DEF 14A · 2026-05-27Read the filing on SEC.gov →
- Akoya Biosciences, Inc. (AKYA)8-K · 2021-12-16Read the filing on SEC.gov →
- PALL CORP10-Q · 2015-02-25Read the filing on SEC.gov →
- PALL CORP10-Q · 2015-05-21Read the filing on SEC.gov →
- Stereotaxis, Inc. (STXS)8-K · 2005-07-14Read the filing on SEC.gov →
- Hutchison China MediTech Ltd20-F · 2017-03-13Read the filing on SEC.gov →
- Cyclerion Therapeutics, Inc. (CYCN)8-K · 2020-07-09Read the filing on SEC.gov →
- PALL CORP10-Q · 2014-03-03Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2022-04-19Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2026-04-14Read the filing on SEC.gov →
- Akoya Biosciences, Inc. (AKYA)8-K · 2023-06-07Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K/A · 2024-04-16Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2024-01-23Read the filing on SEC.gov →
- Hutchison China MediTech Ltd6-K · 2019-05-02Read the filing on SEC.gov →
- Jounce Therapeutics, Inc.8-K · 2019-09-04Read the filing on SEC.gov →
- INFINITY PHARMACEUTICALS, INC. (INFIQ)8-K · 2017-11-13Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2024-04-16Read the filing on SEC.gov →
- Cabaletta Bio, Inc. (CABA)8-K · 2026-05-14Read the filing on SEC.gov →
- AVEO PHARMACEUTICALS INCS-1 · 2009-12-16Read the filing on SEC.gov →
- Forte Biosciences, Inc. (FBRX)8-K · 2020-09-09Read the filing on SEC.gov →
- Jounce Therapeutics, Inc.8-K · 2018-11-09Read the filing on SEC.gov →
- Translational Development Acquisition Corp.DEFA14A · 2026-05-28Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2021-04-20Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2022-10-18Read the filing on SEC.gov →
- Cabaletta Bio, Inc. (CABA)8-K · 2026-05-14Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2022-07-19Read the filing on SEC.gov →
- PALL CORP10-Q · 2014-12-02Read the filing on SEC.gov →
- PALL CORP10-Q · 2014-06-02Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2020-10-13Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2019-10-15Read the filing on SEC.gov →
- IDERA PHARMACEUTICALS, INC.8-K · 2019-01-07Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2025-07-16Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2025-04-15Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2025-10-14Read the filing on SEC.gov →
- ONCOLYTICS BIOTECH INC (ONCY)6-K · 2025-12-16Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2026-07-15Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2023-10-17Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2025-01-22Read the filing on SEC.gov →
- JOHNSON & JOHNSON (JNJ)8-K · 2023-01-24Read the filing on SEC.gov →
Source: the SEC’s own EDGAR full-text index, which covers filings from 2001onward. Results are ordered by EDGAR’s relevance. A filing appearing here means the phrase is in the document, nothing more. EDGAR caps its match count at 10,000 and reports anything above that as a lower bound, so the figure above is a floor rather than an exact total.